L.C. Coates, MB ChB, PhD, National Institute for Health Research Clinician Scientist, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK.
J Rheumatol Suppl. 2021 Jun;97:65-66. doi: 10.3899/jrheum.201681.
Throughout 2020, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has been working to update the GRAPPA treatment recommendations for psoriasis and psoriatic arthritis (PsA). The planned methodology for this update was published previously, and herein we provide an update on progress so far, including details of the systematic literature searches undertaken. GRAPPA is committed to regular updates of its treatment recommendations to incorporate the many significant therapeutic advances that have taken place in the PsA literature since the previous recommendation publication in 2015. The development and updating of treatment recommendations for optimal treatment approaches for patients with PsA has been an important mission of the GRAPPA since its inception. GRAPPA is currently finalizing domain-specific recommendations with an aim to produce updated treatment recommendations for publication in 2021.
2020 年期间，银屑病和银屑病关节炎研究与评估团体（GRAPPA）一直致力于更新银屑病和银屑病关节炎（PsA）的 GRAPPA 治疗建议。该更新的计划方法之前已经公布，本文提供了迄今为止的进展情况更新，包括所进行的系统文献检索的详细信息。GRAPPA 致力于定期更新其治疗建议，以纳入自 2015 年上次推荐出版物以来，PsA 文献中发生的许多重要治疗进展。自成立以来，为患者制定最佳治疗方法的治疗建议的制定和更新一直是 GRAPPA 的一项重要任务。GRAPPA 目前正在敲定特定领域的建议，旨在制定更新的治疗建议并于 2021 年出版。
